Kally Singh

Kally Singh has over 20 years of experience in the pharmaceutical industry. Kally is currently serving as the Executive Director of Intellectual Property & Contracts at ESSA Pharma, a position they have held since September 2021. Prior to this, Kally worked as a Principal at KNS Consulting starting in 2012. From 2004 to 2012, they served as the Director of Intellectual Property at Cardiome Pharma Corp. Before that, they held the position of Intellectual Property Manager at Inflazyme Pharmaceuticals Ltd from 2001 to 2004. Kally's career in the pharmaceutical industry began in 1998 when they worked as a Scientific Information Coordinator at Angiotech Pharmaceuticals Inc until 2001.

Kally Singh holds an Executive MBA degree in Business from Queen's University. Additionally, Kally has an MSc degree in Science from King's College London and a BSc degree in Biological Sciences from Simon Fraser University. In terms of additional certifications, Kally is a Certified Licensing Professional from the Licensing Executives Society and a Certified Patent Valuation Analyst from The Business Development Academy.